Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay

Targeting the interaction between the spike protein receptor binding domain (S-RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and angiotensin-converting enzyme 2 (ACE2) is a potential therapeutic strategy for treating coronavirus disease 2019 (COVID-19). However, we still lack...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Yusen, Zhai, Guanglei, Li, Yaozong, Wang, Mengge, Chen, Xixiang, Wang, Ruyu, Xie, Hang, Zhang, Weidong, Ge, Guangbo, Zhang, Qian, Xu, Yechun, Caflisch, Amedeo, Xu, Jianrong, Chen, Hongzhuan, Chen, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743696/
https://www.ncbi.nlm.nih.gov/pubmed/36521705
http://dx.doi.org/10.1016/j.ijbiomac.2022.12.057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743696/
https://www.ncbi.nlm.nih.gov/pubmed/36521705
http://dx.doi.org/10.1016/j.ijbiomac.2022.12.057

Ejemplares similares